Evidence map›Paper›PMID 39519731›Full record

ReviewMolecules (Basel, Switzerland)2024

Hybrid Metal Catalysts as Valuable Tools in Organic Synthesis: An Overview of the Recent Advances in Asymmetric C─C Bond Formation Reactions.

Isabella Rimoldi, Giulia Coffetti, Raffaella Gandolfi, Giorgio Facchetti

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isabella RimoldiDepartment of Pharmaceutical Sciences, University of Milan, Via Venezian 21, 20133 Milano, Italy.ORCID 0000-0002-6210-0264
Giulia CoffettiDepartment of Pharmaceutical Sciences, University of Milan, Via Venezian 21, 20133 Milano, Italy.
Raffaella GandolfiDepartment of Pharmaceutical Sciences, University of Milan, Via Venezian 21, 20133 Milano, Italy.ORCID 0000-0003-2145-8574
Giorgio FacchettiDepartment of Pharmaceutical Sciences, University of Milan, Via Venezian 21, 20133 Milano, Italy.ORCID 0000-0002-1260-1335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon-carbon bond formation represents a key reaction in organic synthesis, resulting in paramount importance for constructing the carbon backbone of organic molecules. However, traditional metal-based catalysis, despite its advantages, often struggles with issues related to efficiency, selectivity, and sustainability. On the other hand, while biocatalysis offers superior selectivity due to an extraordinary recognition process of the substrate, the scope of its applicable reactions remains somewhat limited. In this context, Artificial Metalloenzymes (ArMs) and Metallo Peptides (MPs) offer a promising and not fully explored solution, merging the two fields of transition metal catalysis and biotransformations, by inserting a catalytically active metal cofactor into a customizable protein scaffold or coordinating the metal ion directly to a short and tunable amino acid (Aa) sequence, respectively. As a result, these hybrid catalysts have gained attention as valuable tools for challenging catalytic transformations, providing systems with new-to-nature properties in organic synthesis. This review offers an overview of recent advances in the development of ArMs and MPs, focusing on their application in the asymmetric carbon-carbon bond-forming reactions, such as carbene insertion, Michael additions, Friedel-Crafts and cross-coupling reactions, and cyclopropanation, underscoring the versatility of these systems in synthesizing biologically relevant compounds.

Indexed as

artificial metalloenzymesenantioselective C─C bond formationhomogeneous catalysismetallo peptidesorganometallic complexesprotein engineering

Identifiers

PMID39519731
PMCPMC11547358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.